GlassScriptPhysician profile
Janet Kline
NPI 1174902449
$2,326.77
in general payments reported to CMS, 2019-2025
16 companies · $580 in 2025
The $580 reported for 2025 was more than what 77% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $808 · 2022: $221 · 2023: $472 · 2024: $245 · 2025: $580.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,213 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,212.50 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $836.86 | 2021-2025 | Opdivo |
| Astrazeneca Pharmaceuticals LP | $350.56 | 2021-2022 | |
| Inari Medical, INC. | $140.03 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Amgen INC. | $125.88 | 2021-2023 | Lumakras |
| Taiho Oncology, INC. | $124.96 | 2021 | |
| Gilead Sciences, INC. | $119.74 | 2025 | Trodelvy |
| Blueprint Medicines Corporation | $114.53 | 2021 | |
| Seagen INC. | $109.04 | 2023 | Tukysa |
| Abbvie INC. | $102.92 | 2021 | |
| Exelixis INC. | $84.99 | 2024 | |
| Illumina, INC. | $79.72 | 2025 | Oncology Testing |
| Astellas Pharma US INC | $64.99 | 2021 | |
| Eisai INC. | $20.18 | 2024 | |
| Genzyme Corporation | $18.90 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $17.27 | 2023 | Libtayo |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Caris Mpi, INC. | $16.20 | 2025 | Mi Cancer Seek |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janet Kline listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.